Advanced Enzyme Technologies Ltd

NSE : ADVENZYMES

BSE: 540025

SECTOR : CHEMICALS

No data to show from BSE

52w high/low	₹503.7 / ₹301.1
P/E ratio	43.22
Dividend	1.34
ROE	18.24
ROCE	23.03
Face value	2
Book value	₹53.82Cr
Market capital	₹4,255.38Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.

Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:

Assets = Liabilities + Shareholder's Equity

This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

PE TTM

43.22

P/B

7.07

ROE

18.24

ROCE

23.03

Dividend yield

1.34%

EPS TTM

9.82

EBTIDA Growth

71.14

D/E

0.01

Sector PE

47.31

₹53.82Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.

About Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Limited (AETL) has transformed in to a global enzyme powerhouse, based on research and technology, development. AETL is largest Indian enzyme company, engaged in the research and development, manufacturing and marketing of 400+ proprietary products developed from over 68 indigenous enzymes and probiotics. AETL is one of the few manufacturers in the world who possess great depth and expertise in fermented enzymes manufacturing. The company caters to diversified industries and verticals like Human Nutrition, Animal Nutrition and Bioprocessing. The company provides its proprietary enzyme products and customized enzyme solutions to various pharmaceutical and nutraceutical companies in India, North America, Asia (ex-India), Europe and other countries globally. The enzymes used by customers are as active ingredients in their pharmaceutical and nutraceutical formulations. AETL has state-of-the-art manufacturing facilities and research & development centers across India, Germany and the US. The company has four wholly owned subsidiaries, two subsidiaries and five step-down subsidiaries as on March 31, 2019.